These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


281 related items for PubMed ID: 33635363

  • 1. Urine osmolality predicts calcium-oxalate crystallization risk in patients with recurrent urolithiasis.
    Kavouras SA, Suh HG, Vallet M, Daudon M, Mauromoustakos A, Vecchio M, Tack I.
    Urolithiasis; 2021 Oct; 49(5):399-405. PubMed ID: 33635363
    [Abstract] [Full Text] [Related]

  • 2. Clinical validation of urinary indole-reacted calcium oxalate crystallization index (iCOCI) test for diagnosing calcium oxalate urolithiasis.
    More-Krong P, Tubsaeng P, Madared N, Srisa-Art M, Insin N, Leeladee P, Boonla C.
    Sci Rep; 2020 May 20; 10(1):8334. PubMed ID: 32433482
    [Abstract] [Full Text] [Related]

  • 3. Assessment of crystallization risk formulas in pediatric calcium stone-formers.
    Sikora P, Zajaczkowska M, Hoppe B.
    Pediatr Nephrol; 2009 Oct 20; 24(10):1997-2003. PubMed ID: 19333626
    [Abstract] [Full Text] [Related]

  • 4. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO, Schmiedl A, Wipplinger J.
    Eur J Med Res; 2009 Sep 01; 14(9):378-92. PubMed ID: 19748857
    [Abstract] [Full Text] [Related]

  • 5. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
    Schwille PO, Schmiedl A, Herrmann U, Fan J, Gottlieb D, Manoharan M, Wipplinger J.
    Urol Res; 1999 Apr 01; 27(2):117-26. PubMed ID: 10424393
    [Abstract] [Full Text] [Related]

  • 6. Upper metastable limit osmolality of urine as a predictor of kidney stone formation in children.
    Porowski T, Kirejczyk JK, Mrozek P, Protas P, Kozerska A, Łabieniec Ł, Szymański K, Wasilewska A.
    Urolithiasis; 2019 Apr 01; 47(2):155-163. PubMed ID: 29356875
    [Abstract] [Full Text] [Related]

  • 7. Simple dietary advice targeting five urinary parameters reduces urinary supersaturation in idiopathic calcium oxalate stone formers.
    Sromicki J, Hess B.
    Urolithiasis; 2020 Oct 01; 48(5):425-433. PubMed ID: 32524204
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy.
    Oehlschläger S, Albrecht S, Hakenberg OW, Schrödter S, Froehner M, Manseck A, Wirth MP.
    Urology; 2003 Jul 01; 62(1):17-21. PubMed ID: 12837412
    [Abstract] [Full Text] [Related]

  • 10. Idiopathic calcium oxalate urinary lithiasis: usefulness of Parks' and Tiselius' indices in the evaluation of the risk of stone formation.
    Robert M, Roux JO, Boularan AM, Bourelly F, Monnier L, Grasset D.
    Urol Int; 1995 Jul 01; 55(2):88-92. PubMed ID: 8533202
    [Abstract] [Full Text] [Related]

  • 11. Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis.
    Karagülle O, Smorag U, Candir F, Gundermann G, Jonas U, Becker AJ, Gehrke A, Gutenbrunner C.
    World J Urol; 2007 Jun 01; 25(3):315-23. PubMed ID: 17333204
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.
    Bek-Jensen H, Tiselius HG.
    Urol Res; 1997 Jun 01; 25(5):365-72. PubMed ID: 9373919
    [Abstract] [Full Text] [Related]

  • 19. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C.
    Scand J Urol Nephrol Suppl; 1990 Jun 01; 130():1-83. PubMed ID: 2291093
    [Abstract] [Full Text] [Related]

  • 20. The composition of four-hour urine samples from patients with calcium oxalate stone disease.
    Berg C, Larsson L, Tiselius HG.
    Br J Urol; 1987 Oct 01; 60(4):301-6. PubMed ID: 3690199
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.